ALX ONCOLOGY HOLDINGS INC (ALXO)
$0.00+$0.00 (+0.00%) TodayExtended Hours
Corey S. GoodmanALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. It is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 3 | 4,207 | $8K |
36 Form 4 filings on record, the earliest from Nov 19, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Shelly Pinto - Officer | Open-market sale | Common Stock | 2,011 | $0.45 | $905 | |
| Shelly Pinto - Officer | Open-market sale | Common Stock | 1,532 | $0.43 | $659 | |
| Rekha Hemrajani | Open-market purchase | Common Stock | 30,000 | $1.55 | $46K | |
| Shelly Pinto - Officer | Grant or award | Employee Stock Option (right to buy) | 150,000 | $0.00 | - | |
| Jason Lettmann - Officer | Grant or award | Employee Stock Option (right to buy) | 200,000 | $0.00 | - | |
| Alan B. Sandler - Officer | Grant or award | Employee Stock Option (right to buy) | 600,000 | $0.00 | - |
This is as far as the anonymous view goes. Create a free account for all 36 ALXO filings on record.
ALX ONCOLOGY HOLDINGS INC (ALXO) had 3 insider filings in the last 90 days, with the most recent on 2026-08-18. The full record for ALXO runs to 36 Form 4 filings, the earliest from 2024-11-19. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of ALXO were filed in the last 90 days. 5 purchases are on record for this company.
3 insider sales of ALXO were filed in the last 90 days, totaling $8K.
This page tracks ALXO Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add ALXO to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
